[ 68 Ga]Ga-HBED-CC-FAPI Derivatives with Improved Radiolabeling and Specific Tumor Uptake
Molecular Pharmaceutics · 2023
DOI: 10.1021/acs.molpharmaceut.2c01112 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2023. Verfasst von Haiyan Hong und 12 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Radiopharmaceuticals, Ministry of Education, College of Chemistry, Beijing Normal University, Beijing 100875, P. R. China. Hauptthemen laut MEDLINE: Gallium Radioisotopes, Positron-Emission Tomography. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Five Eleven Pharma Inc..
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Radiopharmaceuticals, Ministry of Education, College of Chemistry, Beijing Normal University, Beijing 100875, P. R. China.
- Five Eleven Pharma Inc., Philadelphia, Pennsylvania 19104, United States.
- Department of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States.
ORCID-Profile: Haiyan Hong, Karl Ploessl, Hank F Kung
Förderung
- Five Eleven Pharma Inc.
Zitieren
APA
Hong, H., Zha, Z., Zhao, R., Luo, Y., Jin, W., Li, L., Wang, R., Yan, L., Wang, H., Ploessl, K., Qiao, J., Zhu, L., & Kung, H. F. (2023). [ 68 Ga]Ga-HBED-CC-FAPI Derivatives with Improved Radiolabeling and Specific Tumor Uptake. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.2c01112
Vancouver
Hong H, Zha Z, Zhao R, Luo Y, Jin W, Li L, et al. [ 68 Ga]Ga-HBED-CC-FAPI Derivatives with Improved Radiolabeling and Specific Tumor Uptake. Molecular Pharmaceutics. 2023. doi:10.1021/acs.molpharmaceut.2c01112
BibTeX
@article{Hong2023,
author = {Hong, Haiyan and Zha, Zhihao and Zhao, Ruiyue and Luo, Yang and Jin, Wenbin and Li, Linlin and Wang, Ran and Yan, Li and Wang, Hui and Ploessl, Karl and Qiao, Jinping and Zhu, Lin and Kung, Hank F},
title = {[ 68 Ga]Ga-HBED-CC-FAPI Derivatives with Improved Radiolabeling and Specific Tumor Uptake},
journal = {Molecular Pharmaceutics},
year = {2023},
doi = {10.1021/acs.molpharmaceut.2c01112}
}
EUVIMED